Abstract
The purpose of this study was to assess the feasibility of administering Ad5CMV-p53, an adenoviral vector containing the wild-type p53 gene to patients with advanced malignancies, characterize the pertinent pharmacokinetic parameters, identify evidence of viral uptake in both normal and tumor tissue, and seek evidence of antitumor activity. Patients were treated with escalating doses of Ad5CMV-p53 intravenously over 30 minutes on days 1, 2, and 3, every 28 days. The clearance of circulating Ad5CMV-p53 (INGN 201) DNA was characterized in the plasma and paired tumor and skin biopsies were performed in patients treated at the two highest dose levels to assess vector uptake into tissues. Seventeen patients received 36 courses of Ad5CMV-p53 at doses ranging from 3 x 10(10) to 3 x 10(12) virus particles (vp). Fatigue, nausea, vomiting, and fever were common, but rarely severe. Abnormalities of coagulation parameters, including decreases in fibrinogen and increases in fibrin degradation products at 3 x 10(12)vp, precluded additional dose escalation. Ad5CMV-p53 DNA could be detected in the plasma by polymerase chain reaction assay in the majority of patients at 14 days and 28 days at doses of 3 x 10(10) and higher. Six patients treated...Continue Reading
References
Jul 5, 1991·Science·M HollsteinC C Harris
Dec 10, 1990·Science·D MalkinM A Tainsky
May 3, 1991·Science·D SidranskyP Frost
Jun 6, 1991·Nature·A J LevineC A Finlay
Oct 5, 1990·Science·O HalevyM Oren
Dec 7, 1989·Nature·J M NigroP Devilee
Oct 27, 1989·Science·T TakahashiJ D Minna
Apr 14, 1989·Science·S J BakerB Vogelstein
Mar 6, 1986·Nature·M IsobeC M Croce
Oct 23, 1997·International Journal of Radiation Oncology, Biology, Physics·H E KimH R Kim
Jun 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G L ClaymanH Goepfert
Jul 1, 1998·Journal of Neurosurgery·F F LangP J Tofilon
Feb 16, 1999·Biochimica Et Biophysica Acta·W KammouniM D Merten
May 18, 1999·Journal of the National Cancer Institute·S G SwisherM K Waugh
Feb 2, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J NemunaitisJ Roth
Apr 19, 2000·Cancer Gene Therapy·S OsakiN Hara
Jun 23, 2001·Gene Therapy·J NemunaitisD Kirn
Jul 24, 2002·Cancer Gene Therapy·Gilles DolivetFrançois Guillemin
Mar 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Steven HirschfeldRichard Pazdur
Jul 4, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Frederick F LangW K Alfred Yung
Oct 22, 2003·Molecular Genetics and Metabolism·Steven E RaperMark L Batshaw
Nov 6, 2003·Journal of Virological Methods·Patrick SaulnierAntoine Yver
Aug 7, 2004·Gynecologic Oncology·Judith K WolfDavid M Gershenson
Citations
Jan 14, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Daniel H StermanSteven M Albelda
Dec 14, 2007·Nature Reviews. Cancer·Dario C Altieri
May 23, 2013·Human Gene Therapy. Clinical Development·Laura TuppurainenSeppo Ylä-Herttuala
Mar 26, 2009·Anti-cancer Drugs·Geng TianJie Sui
Mar 17, 2009·Anti-cancer Drugs·Geng TianWeihong Chen
Mar 19, 2008·Molecular Cancer Therapeutics·James F CurtinMaria G Castro
Jul 16, 2009·The Journal of Clinical Investigation·Tomoya TerashimaLawrence Chan
Aug 24, 2010·Journal of Translational Medicine·Sergio Lavilla-AlonsoSari Pesonen
Feb 25, 2011·PloS One·J Michael MathisDavid T Curiel
Aug 13, 2013·PloS One·Branka StancevicRichard Kolesnick
Sep 28, 2007·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Ute FischerKlaus Schulze-Osthoff
Jun 7, 2013·Therapeutic Delivery·Stephany Y Tzeng, Jordan J Green
Dec 11, 2007·Leukemia & Lymphoma·Todd KelleyEric Hsi
Sep 15, 2010·Expert Review of Anticancer Therapy·Sandra Schmitz, Jean-Pascal Machiels
Oct 20, 2006·Expert Opinion on Biological Therapy·Christopher Y WooMichael A Morse
Feb 27, 2009·Expert Opinion on Investigational Drugs·Patricia Moretto, Sébastien J Hotte
Jul 22, 2006·Expert Opinion on Biological Therapy·Dmitry I Gabrilovich
Apr 29, 2014·ACS Nano·Hugo Guerrero-CázaresJordan J Green
Jun 11, 2009·Drug Discovery Today·Pin-I HuangTa-Chiang Liu
May 7, 2008·Journal of Cellular Biochemistry·Jessica PlatiRoya Khosravi-Far
Oct 13, 2010·Alimentary Pharmacology & Therapeutics·Y TouchefeuG Vassaux
Apr 19, 2016·Molecular Therapy. Methods & Clinical Development·Guy UngerechtsDirk M Nettelbeck
Jul 6, 2013·Regulatory Toxicology and Pharmacology : RTP·Pei-jian YueYing Peng
Jan 17, 2015·Regulatory Toxicology and Pharmacology : RTP·Pei-jian YueYing Peng
May 26, 2017·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Rami Walid ChakrounHonggang Cui
Jan 18, 2018·Human Gene Therapy·Wei-Wei ZhangDominic Man-Kit Lam
Jan 12, 2007·Leukemia·W J ChngR Fonseca
Sep 21, 2007·The Journal of Gene Medicine·Ellen A M Schenk-BraatLeonie C M Kaptein
Jun 18, 2017·Cancer Gene Therapy·H SaitoT Shirakawa
Apr 7, 2016·Oncotarget·Shumin ZhangDaqing Wu
Jul 7, 2015·Anti-cancer Drugs·Keqiang LiuJianping Chen